- Home
- UNB vs IMA Comparison
UNB vs IMA Comparison
Compare UNB & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNB
- IMA
- Stock Information
- Founded
- UNB 1891
- IMA 2019
- Country
- UNB United States
- IMA United States
- Employees
- UNB N/A
- IMA N/A
- Industry
- UNB Major Banks
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UNB Finance
- IMA Health Care
- Exchange
- UNB Nasdaq
- IMA Nasdaq
- Market Cap
- UNB 99.3M
- IMA 92.2M
- IPO Year
- UNB 1998
- IMA N/A
- Fundamental
- Price
- UNB $22.99
- IMA $7.05
- Analyst Decision
- UNB
- IMA Buy
- Analyst Count
- UNB 0
- IMA 1
- Target Price
- UNB N/A
- IMA $30.00
- AVG Volume (30 Days)
- UNB 11.1K
- IMA 37.4K
- Earning Date
- UNB 11-10-2025
- IMA 11-12-2025
- Dividend Yield
- UNB 6.21%
- IMA N/A
- EPS Growth
- UNB 27.30
- IMA N/A
- EPS
- UNB 2.47
- IMA N/A
- Revenue
- UNB $52,533,000.00
- IMA $800,000.00
- Revenue This Year
- UNB N/A
- IMA N/A
- Revenue Next Year
- UNB N/A
- IMA N/A
- P/E Ratio
- UNB $9.40
- IMA N/A
- Revenue Growth
- UNB 13.25
- IMA N/A
- 52 Week Low
- UNB $20.65
- IMA $6.94
- 52 Week High
- UNB $37.70
- IMA $18.00
- Technical
- Relative Strength Index (RSI)
- UNB 48.98
- IMA N/A
- Support Level
- UNB $21.50
- IMA N/A
- Resistance Level
- UNB $23.33
- IMA N/A
- Average True Range (ATR)
- UNB 0.72
- IMA 0.00
- MACD
- UNB 0.09
- IMA 0.00
- Stochastic Oscillator
- UNB 80.17
- IMA 0.00
About UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.